Data presented at EAU 2026 show an 89 percent complete response rate in intermediate-risk disease...
PR Newswire
Biophytis and LynxKite launch new modalities beyond MASSIVE: AI-driven drug discovery for next-generation longevity therapies This...
Die neue Plattform eliminiert hydrodynamische Scherbelastung und skaliert isometrisch von 50 mL bis 250 mL mit dem...
BioDlink has been named “Emerging CDMO of the Year” for its innovation in complex biologics...
VANCOUVER, BC, March 13, 2026 /PRNewswire/ — Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven...
SHANGHAI, March 13, 2026 /PRNewswire/ — On March 12, Unixell Biotech achieved a significant milestone as...
STATEN ISLAND, N.Y., March 13, 2026 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or...
STOCKHOLM, March 13, 2026 /PRNewswire/ — January 1 – December 31, 2025 The fourth quarter...
SINGAPORE, March 12, 2026 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract...
— Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining...